GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » Debt-to-EBITDA

Omid Holdings (Omid Holdings) Debt-to-EBITDA : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is Omid Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Omid Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Omid Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Omid Holdings's annualized EBITDA for the quarter that ended in . 20 was $0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Omid Holdings's Debt-to-EBITDA or its related term are showing as below:

OMID's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.7
* Ranked among companies with meaningful Debt-to-EBITDA only.

Omid Holdings Debt-to-EBITDA Historical Data

The historical data trend for Omid Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omid Holdings Debt-to-EBITDA Chart

Omid Holdings Annual Data
Trend
Debt-to-EBITDA

Omid Holdings Quarterly Data
Debt-to-EBITDA

Competitive Comparison of Omid Holdings's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omid Holdings's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Omid Holdings's Debt-to-EBITDA falls into.



Omid Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Omid Holdings's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Omid Holdings's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (. 20) EBITDA data.


Omid Holdings  (OTCPK:OMID) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Omid Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Omid Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Omid Holdings (Omid Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.

Omid Holdings (Omid Holdings) Headlines

From GuruFocus

OMID Provides Fourth-Quarter Financial Highlights

By PRNewswire PRNewswire 01-14-2021

OMID Holdings Discloses New Corporate Initiatives

By PRNewswire PRNewswire 02-17-2021

OMID Reports Strong Second-Quarter Financial Results

By PRNewswire PRNewswire 09-16-2020

OMID Holdings, Inc. Issues Shareholder Letter

By PRNewswire PRNewswire 03-02-2021

OMID Posts Second Quarter Financial Statements

By PRNewswire PRNewswire 08-10-2021

OMID Holdings, Inc. Issues a Letter to Shareholders

By PRNewswire PRNewswire 02-26-2020

OMID Makes Strategic Investment Into Psychedelic Medicine

By PRNewswire PRNewswire 08-12-2021

OMID Provides Third-Quarter Financial Highlights

By PRNewswire PRNewswire 10-12-2021

OMID Provides Third-Quarter Financial Results

By PRNewswire PRNewswire 10-16-2020